StockData

Jack Henry & Associates vs Waystar

JKHY and WAY side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How JKHY and WAY compare

Jack Henry & Associates is the larger company, worth 2.1 times as much as Waystar ($11.3B against $5.4B).

On earnings, Jack Henry & Associates is cheaper: it trades at 23.1× trailing earnings, against 40.0× for Waystar.

Waystar grew revenue faster over the last twelve months (19.2% versus 7.1% for Jack Henry & Associates).

Jack Henry & Associates keeps more of each dollar of sales as profit, with a net margin of 19.8% compared with 11.2% at Waystar.

Jack Henry & Associates pays a dividend yielding 1.5%; Waystar does not pay one.

Jack Henry & Associates scores higher on the StockData Score (24 against 12 for Waystar), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricJKHYWAY
Size and price
Market cap$11.3B$5.4B
Share price$161.34$28.00
Change, 1 year7.6%−29.3%
Change, 5 years1.9%–
Beta (5Y)0.450.94
Employees7,300340
StockData Score
Total score24 (better)12
Valuation score4 (better)3
Growth score44
Performance score6 (better)3
Health score6 (better)2
Dividend score4 (better)0
Valuation
P/E23.1× (better)40.0×
P/S4.4× (better)4.5×
P/B5.5×1.3× (better)
EV/EBITDA17.8×15.4× (better)
P/FCF16.3× (better)21.8×
PEG1.99–
FCF yield6.1% (better)4.6%
Fair value$182.31$29.74
Margin of safety11.5% (better)5.9%
Growth
Revenue growth (TTM)7.1%19.2% (better)
Revenue growth, 5Y average7.7%–
Net income growth (TTM)10.3%56.8% (better)
EPS growth (TTM)11.9%45.8% (better)
EPS growth, 5Y average11.1%–
Profitability
Gross margin43.7%69.1% (better)
Operating margin25.0% (better)22.9%
Net margin19.8% (better)11.2%
FCF margin27.3% (better)20.4%
Return on equity24.0% (better)3.8%
Return on invested capital24.0% (better)4.1%
Financial health
Debt / equity0.000.37 (better)
Net debt / EBITDA–2.95
Current ratio1.171.85 (better)
Altman Z-score9.36 (better)2.11
Piotroski F-score8 (better)7
Dividends and buybacks
Dividend yield1.5%–
Payout ratio33.9%–
Years of dividend growth17–
Dividend growth, 5Y average6.0%–
Buyback yield3.9%–
Shareholder yield5.4% (better)0.00%
Ownership
Held by institutions99.1%110%
Held by insiders0.61%63.6%
Insider net buying, 12 months−$3.2M (better)−$8.2M
Short interest, % of float6.9%22.9%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.